“一个月降糖见效,无效退款”,“进口”控糖饮涉虚假宣传
Bei Ke Cai Jing·2025-08-27 05:40

Core Viewpoint - The article highlights the misleading marketing practices of certain dietary supplements claiming to control blood sugar levels, emphasizing that these products are not a cure for diabetes and may not have the efficacy they advertise [1][2][3]. Group 1: Product Claims and Marketing Tactics - Products like "Kongtangwei" and "Breorqy Bitter Melon Peptide Drink" falsely claim to be "imported from the USA" while being produced domestically [1][4]. - These products assert that they can repair pancreatic cells, reverse diabetes, and allow patients to stop medication, which is considered false advertising by medical experts [2][3]. - Marketing strategies include comparing their products unfavorably to established diabetes medications, emphasizing the supposed lack of side effects and dependency [9][10]. Group 2: Regulatory and Legal Concerns - Dietary supplements in China are classified as ordinary food and cannot legally claim therapeutic effects, which these products do [3][11]. - The advertising practices of these products violate Chinese advertising laws that prohibit non-medical products from claiming to treat diseases [11][12]. Group 3: Consumer Experiences and Feedback - Consumers report that despite using these products, their blood sugar levels did not improve, leading to refund requests and complaints about false advertising [19][21]. - Some consumers expressed skepticism about the authenticity of positive reviews, suspecting they may be fabricated [21][22]. Group 4: Production and Cost Analysis - The production cost of these products is significantly lower than their retail price, with estimates suggesting a production cost of around 10 yuan per bottle, while they are sold for over 160 yuan [24][25]. - The products are marketed as having advanced formulations, but the actual ingredients and their efficacy are often misrepresented [22][23]. Group 5: Scientific Validity of Ingredients - Ingredients like Noni juice and Bitter Melon peptide are claimed to have blood sugar-lowering effects, but medical professionals indicate that there is insufficient evidence to support these claims [27][28][29]. - Experts emphasize that no single product can effectively treat all diabetes patients, highlighting the need for individualized treatment plans [29].